Reuters reported on Friday that Johnson & Johnson (NYSE: JNJ) knew for decades that its baby powder sometimes contained the known carcinogen asbestos.

According to the report, the pharmaceutical and health care products provider knew that its raw talc and finished powder tested positive for traces of asbestos. Reuters cited court documents linked to a case in Missouri, where $4.7 billion was awarded to 22 women who claimed that these products caused them to develop ovarian cancer.

Separately, Reuters alleges that the company attempted to influence U.S. regulators to reduce the amount of asbestos that could legally remain in some of its cosmetic talc products.

Ernie Knewitz, Johnson & Johnson’s vice president of global media relations, told Reuters in an email:

Plaintiffs’ attorneys out for personal financial gain are distorting historical documents and intentionally creating confusion in the courtroom and in the media. This is all a calculated attempt to distract from the fact that thousands of independent tests prove our talc does not contain asbestos or cause cancer. Any suggestion that Johnson & Johnson knew or hid information about the safety of talc is false.

Shares of Johnson & Johnson were last seen down about 9% at $134.44 on Friday, in a 52-week range of $118.62 to $148.99. The consensus analyst price target is $148.56.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.